GlassScriptPhysician profile
Claudia Younany
NPI 1326690116
$2,272.49
in general payments reported to CMS, 2019-2025
13 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $249 · 2021: $212 · 2022: $383 · 2023: $948 · 2024: $312 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $613.49 | 2020-2025 | Acuvue |
| Alcon Vision LLC | $446.39 | 2021-2024 | Total30, Precision 1, Eysuvis |
| Biotissue Holdings INC. | $249.14 | 2022-2024 | |
| Coopervision INC. | $229.85 | 2022-2024 | Myday Contact Lens, Misight Contact Lens, Paragon Crt |
| Sight Sciences, INC. | $206.85 | 2020-2023 | Tearcare System |
| Johnson & Johnson Surgical Vision, INC. | $202.96 | 2021-2024 | One Series Ultra, Lipiflow System Activator (Disposable) |
| Bausch & Lomb Americas INC. | $148.91 | 2023 | Miebo |
| Oyster Point Pharma, INC. | $58.01 | 2023 | Tyrvaya |
| Thea Pharma INC. | $37.70 | 2022-2023 | Iyuzeh |
| Tearlab Corp | $27.81 | 2021 | |
| Abbvie INC. | $18.54 | 2022 | |
| Sun Pharmaceutical Industries INC. | $17.88 | 2020 | |
| Lumenis, INC | $14.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudia Younany listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.